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"lhe effect of  PiPe and di~eyllllyeerol (products of polypho~phoin0~itidc urnover) on the activation level of phosphorylatien of the haman blain 
n©urOll~-Cifie protein 51 by PKC from the saner sotJree wa~ studied. The appnren| .etivmion construct of Ihc phosphorylation process we: shown 
to decrease in the pr©sen¢© ol" PlP~ from I. I t~g/ml 1o 0,2 #lt[ml for PI and from 0.11/~g/ml to0.6 #glml for PS; thQ value of 0.4/~l~ml in the latter 
¢a~ was d~leclcd rn©re|y after the addition of DOO into th© reaction mixture, Polyphosphoinositidcs are suilllest6'd to play a role in .¢tivatin~ 
PKC.m©diat©d phosphoryl,tion ofSI in nerve terminals, 
Synansin 1: Protein kinase C; Pho~phorylation: Polyphmpholnosltide; Diaeyll|lycerol; Activation 
I. INTRODUCTION 
In our previous tudies [1,2], the neurospecific pro- 
tein SI that acts either as a peculiar anchor of synaptic 
vesicles or as a means for their transportation in nerve 
terminals [3,41 was shown to be effectively and specifi- 
cally phosphorylated not only by cAMP-dependent 
protein kinase and Ca 2., calmodulin-dependent pro- 
tein kinase II, which has been reported by other authors 
as well [5], but also by Ca =*, phospholipid-dependent 
protein kinase (protein kinase C). The fact of PKC. 
dependent SI phosphorylation was earlier noted by 
Greengard et el. in some reviews [6], but the process 
was denied any physiological significance, unlike 
PK II-mediated phosphorylatiorl which is believed to 
lead to the secretion of neurotran:mitter [7]. 
We used homogeneous human brain SI for detailed 
kinetic studies of the protein phosphorylation byPKC 
as well as for establishing the relationship between this 
process and PK II-dependent SI phosphorylation. The 
maximal rates of the two above processes are virtually 
the same, and the Km value with respect to SI 
phosphorylated by PKC amounts to 0.25/zM (80 kDa 
per Mr of SI), which is comparable and even lower than 
Km for other protein kinases phosphorylating this 
neurospecific protein [8,9]. These results allow a sug- 
gestion that SI is a physiological substrata for PKC as 
well, 
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We have also managed to demonstrate hat the pro- 
cess of ¢almodulin and phospholipid,mediated SI 
phosphorylation are interrelated, i.e. PKC activators 
(fatty acids and acidic phospholipids) inhibit PK lI- 
modulated phosphorylation, whereas calmodulin, a 
PK II stimulator, suppresses PKC-dependent SI 
phosphorylation [2], 
The capacity of PKC for activating neurosecretion 
processes has been described by a number of authors 
[10-12]. The reported findings together with our data 
evidence possible occurrence of PKC-dependent Sl 
phosphorylation in v~vo, though the actual significance 
of the process remains yet unclear. In this connection 
we thought it of interest to undertake a detailed study 
of regulatory mechanisms of this phosphorylation. 
2. MATERIALS AND METHODS 
Purification procedure of human brain SI was that proposed by 
Ueda and Greengard [13] with some modifications detailed in [14]. 
PKC was isolated from human brain by the method similar ~o the 
previously described one [15]. 
Bovine brain PIPz was obtained as described elsewhere [16], 
Phosphorylation of SI by PKC was carried out as described 
previously [15], except hat SI was used as the substrate ~nstead of 
histone H 1, 
Protein concentration was determined according to Bradford [17]. 
Reagents used in the study were [~.-32P]ATP (1000 Ci/mmol) from 
Amersham; Tris. ATP, PS, P1 and DOG, from Sigma; EGTA, CaClz 
and other salts from Serve, 
3. RESULTS AND DISCUSSION 
Earlier, in our investigations Of PKC-mediated 
histone H1 phosphorylation [15] we carefully analysed 
the kinetics of rat brain PKC activation by acidic 
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phospholipids; A highly effective stimulating action of 
PI, comparable to that exhibited by the recognized ac- 
tivator PS was detected. Some arguments were produc- 
ed against he originally supposed ecisive role of PS 
alone in the PKC activation in vivo, Any facts in sup- 
port of possible involvement of polyphosphoinositides 
as physiological modulators in this phosphotransferase 
system are extremely important for better, more com- 
prehensive understanding of the extracellular signal 
transduction, including the lipid metabolism system as 
an integral part of this process [18]. 
Analysis of Ca 2+, phospholipid-dependent phos- 
phorylation of the neurospecific protein synapsin I
from this point of view appears of a particular interest, 
because it could provide new experimental data relating 
to the neurotransmission pathways, provided that the 
process in question is assumed to be one of the ways of 
the neurosecretion regulation. 
Since acidic phospholipids proved to be effective ac- 
tivators of PKC-mediated SI phosphorylation [2], we 
0,01=~ 
studied th= effect produced by the products of the 
phosphoinositide turnover phosphatidylinositol-4,5- 
bisphosphate and diacylglycerol n the activation level 
of this process by PS and PI. It should be noted that 
the actual ratio of polyphosphoinositides and diacyl- 
glycerol in the membranes of nerve cells was taken into 
account [19]. 
As can be seen in Fig. 1, the addition into the incuba- 
tion medium of PIPz (at a concentration f 0.5 .g/ml) 
was followed by a S-fold decrease in the K.~ value for 
PI: viz. from 1.1 to 0.2,ug/ml, the analogous ex- 
periments for DOG show K=~ about 0.5/~g/ml (Table J,). 
It is noteworthy that in case of PKC-mediated 
phosphorylation of histone HI ,  similar experimental 
conditions did not affect so essentially the affinity of 
the phospholipid for the enzyme (data not shown) as 
was the case with SI. 
PIPz is known to be capable of stimulating under 
certain conditions histone HI phosphorylation [20],. 
Besides that, selectivity of phospholipids in PKC ac- 
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t ivadon depends 1o a ~teat ~xtent on the character o r  
the substr,~t~.pho~pholipid Interaction [21]. Apparent- 
[y, in our case. too, the introduction into the lll~id 
bilayer o f  an addit iona| negative chari~e appears more 
preferable for this substrata nd thus provides another 
evidence in favor of phystoloitlcal sil!nificance of  Ca =. , 
phospholipid-dependent SI pho~phorylaflon, 
A similar comparison was carried out for a conven- 
tional PKC activator PS, in which case the g~ value of  
PKC.mediated SI phosphorylation of  0.8,~s/ml (,close 
to that for PI) remained almost the same (0 ,6 ~ lml )  in 
the presence of  PIP= and decreased 2-fold (0,4 t,[llml) 
after th~ addition of  DOG,  a recognized physiological 
activator of  PKC (Fig, 2), So the affinity of  the lipid 
for the enzyme in the latter case was even lower than 
that for the PI + PIPz mixture (K~ = 0.2 t~g/ml) (Table 
I). 
It is a well.known fact that PKC activation by mem- 
brane iipids is preceded by elevation of intraceliular 
calcium and the following enzyme translocation (o the 
membrane [22], 
Since the PS content in the membrane;  of  nerve cells 
is 2 -3  times higher compared to the PI concentration 
[19] and the affinity o f  PKC for PI in ~h¢ presenc~ of 
PIP= is greater than for PS in the presence of  both PIP= 
and DOG,  it is reasonable to suggest that PIP~, like 
diacylglycerol, can be a physiological activator of PKC- 
dependent S[ phosphorylat ion i  nerve cells, However, 
while DAG modulates PKC activity in case of receptor- 
dependent degradation of  phosphoinositides (par- 
ticularly PIP~, as this leads to an increased concentra- 
tion of intracellular Ca~*), PIP~ will be potent of 
activating PKC in the absence of  a hormonal signal. 
One should mind though that in nerve terminals 
depolarization and subsequent elevation of in- 
~racellular calcium will be followed by PKC transloca. 
tion both to the cytoplasmtc membrane and the 
membranes of  intracellular organelles, in particular 
those of synaptic vesicles. In the meantime, z~o data are 
available yet in literature concerning the presence in the 
synaptic vesicle membranes of the enzyme complex: 
receptor /G-prote in/phosphol ipase C, and consequent- 
ly, the entire system of intracellular ealization of  an 
external signal, including products of  the receptor- 
dependent degradation of PI (DOG). So. the primary 
role in activating PKC-mediated SI phosphorylation 
belongs in this case in all likelihood to polyphosphoino- 
sitides, rather than diacylglycerols. The advanced sup- 
position correlates well with the kinetic characteristics 
of  the process under consideration that are summarized 
in Table I. 
Table I 
A~llV~ll~n ~I' PKC~.d,~pvt~d¢,l~l ~1 phts~phoryl~lto~ by acidic 
Pho~phol~pid~ 
A¢ltvalton ~l|'qai|l Lipid Lipid* PIP= Lipid ~, DOG 
K,~ (PI) i . I  ~ 0.1 0.20 ~ 0.03 0,$0 ~ 0.0'3 
K; IPS~ O,t~ ;~ O. i 0.60 ~ 0.08 0,40 -z O.05 
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